BlackRock’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.18M Buy
3,322,219
+129,771
+4% +$189K ﹤0.01% 3819
2025
Q4
$3.67M Sell
3,192,448
-202,524
-6% -$278K ﹤0.01% 3941
2025
Q3
$4.58M Buy
3,394,972
+40,303
+1% +$45.7K ﹤0.01% 3812
2025
Q2
$3.17M Sell
3,354,669
-6,658,338
-66% -$4.31M ﹤0.01% 3937
2025
Q1
$4.61M Sell
10,013,007
-320,151
-3% -$202K ﹤0.01% 3677
2024
Q4
$7.63M Buy
10,333,158
+200,144
+2% +$241K ﹤0.01% 3553
2024
Q3
$15.9M Buy
10,133,014
+242,861
+2% +$433K ﹤0.01% 3175
2024
Q2
$16.6M Buy
9,890,153
+2,196,876
+29% +$3.94M ﹤0.01% 3088
2024
Q1
$18.5M Buy
7,693,277
+688,124
+10% +$1.48M ﹤0.01% 3035
2023
Q4
$10.7M Buy
7,005,153
+350,187
+5% +$416K ﹤0.01% 3363
2023
Q3
$7.25M Buy
6,654,966
+275,780
+4% +$484K ﹤0.01% 3505
2023
Q2
$14.6M Buy
6,379,186
+722,259
+13% +$1.92M ﹤0.01% 3220
2023
Q1
$13.7M Sell
5,656,927
-195,558
-3% -$448K ﹤0.01% 3158
2022
Q4
$11.2M Buy
5,852,485
+92,485
+2% +$197K ﹤0.01% 3345
2022
Q3
$13.8M Buy
5,760,000
+1,240,171
+27% +$3.43M ﹤0.01% 3248
2022
Q2
$8.41M Buy
4,519,829
+74,077
+2% +$141K ﹤0.01% 3594
2022
Q1
$9.29M Sell
4,445,752
-102,172
-2% -$283K ﹤0.01% 3616
2021
Q4
$17.9M Sell
4,547,924
-102,746
-2% -$499K ﹤0.01% 3338
2021
Q3
$22.4M Buy
4,650,670
+3,811
+0.1% +$15.6K ﹤0.01% 3208
2021
Q2
$21.3M Buy
4,646,859
+742,712
+19% +$3.58M ﹤0.01% 3256
2021
Q1
$22.9M Buy
3,904,147
+970,186
+33% +$6.72M ﹤0.01% 3114
2020
Q4
$10M Sell
2,933,961
-967,183
-25% -$1.84M ﹤0.01% 3356
2020
Q3
$5.62M Sell
3,901,144
-315,828
-7% -$562K ﹤0.01% 3520
2020
Q2
$8.41M Buy
4,216,972
+195,227
+5% +$383K ﹤0.01% 3284
2020
Q1
$7.84M Sell
4,021,745
-32,889
-0.8% -$97.9K ﹤0.01% 3119
2019
Q4
$16.8M Sell
4,054,634
-89,309
-2% -$344K ﹤0.01% 2977
2019
Q3
$12.5M Buy
4,143,943
+84,385
+2% +$261K ﹤0.01% 3106
2019
Q2
$25.5M Sell
4,059,558
-71,964
-2% -$431K ﹤0.01% 2708
2019
Q1
$23M Sell
4,131,522
-225,204
-5% -$1.37M ﹤0.01% 2675
2018
Q4
$28.9M Sell
4,356,726
-50,915
-1% -$412K ﹤0.01% 2531
2018
Q3
$47M Sell
4,407,641
-14,652
-0.3% -$168K ﹤0.01% 2408
2018
Q2
$53.1M Buy
4,422,293
+195,461
+5% +$2M ﹤0.01% 2331
2018
Q1
$36.2M Sell
4,226,832
-129,076
-3% -$1.19M ﹤0.01% 2450
2017
Q4
$43M Sell
4,355,908
-475,745
-10% -$4.94M ﹤0.01% 2382
2017
Q3
$59.4M Buy
4,831,653
+172,524
+4% +$2.55M ﹤0.01% 2182
2017
Q2
$76.6M Sell
4,659,129
-199,361
-4% -$3.09M ﹤0.01% 1977
2017
Q1
$69.7M Buy
4,858,490
+4,841,782
+28,979% +$71.8M ﹤0.01% 2021
2016
Q4
$231K Sell
16,708
-2,224
-12% -$35.7K ﹤0.01% 2053
2016
Q3
$342K Buy
18,932
+15,661
+479% +$252K ﹤0.01% 1885
2016
Q2
$47K Sell
3,271
-1,462
-31% -$19.8K ﹤0.01% 2964
2016
Q1
$57K Buy
4,733
+3,778
+396% +$39.6K ﹤0.01% 2299
2015
Q4
$13K Buy
955
+57
+6% +$701 ﹤0.01% 2763
2015
Q3
$10K Hold
898
﹤0.01% 2727
2015
Q2
$7K Hold
898
﹤0.01% 2990
2015
Q1
$6K Hold
898
﹤0.01% 2976
2014
Q4
$6K Hold
898
﹤0.01% 3005
2014
Q3
$9K Buy
898
+178
+25% +$1.9K ﹤0.01% 2792
2014
Q2
$8K Sell
720
-140
-16% -$1.5K ﹤0.01% 2927
2014
Q1
$10K Hold
860
﹤0.01% 2706
2013
Q4
$11K Hold
860
﹤0.01% 2661
2013
Q3
$14K Hold
860
﹤0.01% 2443
2013
Q2
$13K Buy
+860
New +$13.1K ﹤0.01% 2503

Other funds holding LXRX